Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4289926
Max Phase: Preclinical
Molecular Formula: C20H25N3O3
Molecular Weight: 355.44
Molecule Type: Small molecule
Associated Items:
ID: ALA4289926
Max Phase: Preclinical
Molecular Formula: C20H25N3O3
Molecular Weight: 355.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(=O)oc2cc(OCCCCCCCCn3cncn3)ccc12
Standard InChI: InChI=1S/C20H25N3O3/c1-16-12-20(24)26-19-13-17(8-9-18(16)19)25-11-7-5-3-2-4-6-10-23-15-21-14-22-23/h8-9,12-15H,2-7,10-11H2,1H3
Standard InChI Key: UCSWIYOSJRXPDJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 355.44 | Molecular Weight (Monoisotopic): 355.1896 | AlogP: 4.11 | #Rotatable Bonds: 10 |
Polar Surface Area: 70.15 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.07 | CX LogP: 3.82 | CX LogD: 3.82 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.40 | Np Likeness Score: -1.02 |
1. Hu Y, Shen Y, Wu X, Tu X, Wang GX.. (2018) Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents., 143 [PMID:29232586] [10.1016/j.ejmech.2017.11.100] |
Source(1):